Established in 2017 and headquartered in Switzerland, TaP Pharmaceuticals AG is dedicated to advancing global healthcare through innovative pharmaceutical research. With U.S. operations managed by our wholly owned subsidiary, Axar Laboratories Inc., and exclusive development services in India
We specialize in end-to-end pharmaceutical development, from concept to commercialization (C2C). Our comprehensive services include formulation, process development, packaging, sourcing, analytical services, clinical trials, regulatory strategy, and intellectual property management. Whether initiating new projects or optimizing existing ones, we ensure a seamless journey from idea to market.
Company Details
- Founded
- -
- Address
- 1672 Railroad St, Corona,california 92878,united States
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://tappharma.ch/
- Keywords
- Specialty Pharmaceutical R&D, Ophthalmics, Nasal, Inhalations, Complex Injectables, Oral Liquids, Topicals, Medicated Chewing Gum, Solid Orals, and drug devicedevelopment support, device design, selection, development and optimization.
- HQ
- Corona, California
Tap Pharmaceuticals Ag Questions
Tap Pharmaceuticals Ag's website is https://tappharma.ch/
Tap Pharmaceuticals Ag's LinkedIn profile is https://www.linkedin.com/company/tap-pharmaceuticals-ag
Tap Pharmaceuticals Ag's industry is
Research Services
Tap Pharmaceuticals Ag's top competitors are
Alvotech,
Sunbay Consulting,
Kenpack Pharma Limited,
Axar Pharma,
Alvogen,
Rerx Therapeutics,
Recipharm,
Axar Pharmaceuticals, Inc.,
Inpharmation,
Pharmaceutical Business Union.
Tap Pharmaceuticals Ag's categories are Research Services
Tap Pharmaceuticals Ag's founding year is 2017
